Ardian, the global private investment house, acquired a 50% ownership stake in Angus Chemical Company from Golden Gate Capital. The investment was driven by Angus's indispensable position within the global Life Sciences value chain. During the pandemic, Angus's nitroalkane derivatives became vital components for the manufacture of diagnostic kits, antibody treatments, vaccines, and high-alcohol hand sanitizers. Ardian's strategy is to use Angus as a platform for a global "Buy-and-Build" strategy, specifically targeting additional specialty chemical companies in Europe and Asia to further diversify its life sciences and personal care portfolio.

ADVANCION (ANGUS CHEMICAL), which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 10.2x average currently observed in the Industry & Manufacturing sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.